Additional Information

Description

Solu-Medrol 125 mg/2 mL is a sterile powder formulation of methylprednisolone sodium succinate, classified as an anti-inflammatory glucocorticoid. This medication is designed for rapid reconstitution and administration using the single-dose Act-O-Vial system. It is primarily indicated for conditions requiring potent anti-inflammatory and immunosuppressive effects. The active ingredient, methylprednisolone sodium succinate, modulates inflammatory pathways by inhibiting cytokine production and suppressing immune cell activity.

Each vial, upon reconstitution, provides 125 mg of methylprednisolone sodium succinate in 2 mL of solution. The reconstituted solution must be used within 48 hours to maintain sterility and effectiveness. The Act-O-Vial system facilitates convenient mixing by combining the diluent and powder in one container, reducing preparation time and minimizing contamination risks.

Solu-Medrol is utilized in a range of acute and chronic conditions, including severe allergic reactions, asthma exacerbations, lupus, and rheumatoid arthritis. It is also employed in managing specific endocrine, dermatologic, and gastrointestinal disorders. The medication can be administered intravenously or intramuscularly, depending on the clinical scenario and patient needs.